Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Kissei designs new series with potent and selective bronchodilating effects

April 28, 1999

News from FASEB: novel activators of CFTR currents developed at European universities

April 23, 1999

University of Michigan team establishes role of IL-17 in pathogenesis of acute lung injury

April 23, 1999

OVA-IL-18 fusion DNA as a novel immunotherapeutic for asthma

April 21, 1999

Preparation, activity, compositions and use of CCR3 receptor antagonists described by Roche

April 20, 1999

T-2585.HCl: a novel, potent and selective PDE4 inhibitor with potential as asthma Rx

April 19, 1999

Ebastine is not approvable, FDA tells RPR

April 15, 1999

Fujirebio presents pyrimidine-based compounds useful for hypoxemia

April 15, 1999

U.S. is country of first launch for single-isomer bronchodilator

April 15, 1999

Results from SAR studies on Ariflo presented by SmithKline Beecham at ACS meeting

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...